Technetium-labeled bone scintigraphy demonstrated Perugini grade 2 myocardial uptake in the absence of monoclonal gammopathy, strongly supporting transthyretin cardiac amyloidosis (ATTR-CM). The gene discussed is TTR; the disease is cardiac amyloidosis.